

The State of Clinical Trials in the U.K. and Europe
Dec 13, 2023
Chris Moore, President of Veeva Europe, shares his insights on the evolving landscape of clinical trials in the U.K. and Europe. He discusses the recent government efforts to revitalize the U.K. life sciences sector, detailing the impact of Brexit and COVID-19. Moore emphasizes the need for improved technology in clinical trial processes, addressing challenges like data fragmentation. He also explores the European Commission's initiatives for a unified medicines market and the potential of AI to enhance efficiency and access in healthcare.
Chapters
Transcript
Episode notes